0001121781-11-000152.txt : 20110516 0001121781-11-000152.hdr.sgml : 20110516 20110516163004 ACCESSION NUMBER: 0001121781-11-000152 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110331 FILED AS OF DATE: 20110516 DATE AS OF CHANGE: 20110516 EFFECTIVENESS DATE: 20110516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHOENIX MEDICAL SOFTWARE, INC. CENTRAL INDEX KEY: 0001393371 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 208273035 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-142979 FILM NUMBER: 11847441 BUSINESS ADDRESS: STREET 1: 604 CREEK VIEW CITY: OVILLA STATE: TX ZIP: 75154 BUSINESS PHONE: 800-843-8179 MAIL ADDRESS: STREET 1: 604 CREEK VIEW CITY: OVILLA STATE: TX ZIP: 75154 FORMER COMPANY: FORMER CONFORMED NAME: TRIPLE A MEDICAL, INC. DATE OF NAME CHANGE: 20070315 NT 10-Q 1 pmsint10q33111.htm PHOENIX MEDICAL SOFTWARE, INC. pmsint10q33111.htm
 
 
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 12b-25

Commission file number: 333-142979

NOTIFICATION OF LATE FILING

(Check One): [  ] Form 10-K [  ] Form 20-F [  ] Form 11-K [X ] Form 10-Q [ ] Form 10D
[ ] Form N-SAR [ ] Form N-CSR

For Period Ended:  March  31, 2011

[  ]
  
Transition Report on Form 10-K
[  ]
  
Transition Report on Form 20-F
[  ]
  
Transition Report on Form 11-K
[  ]
  
Transition Report on Form 10-Q
[  ]
  
Transition Report on Form N-SAR

For the Transition Period Ended: ___________________

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: _______________________________________________


PART I
REGISTRANT INFORMATION

PHOENIX MEDICAL SOFTWARE, INC.
 (Full name of registrant)

N/A
(Former name if applicable)

604 Creekview
(Address of principal executive office (street and number))

Ovilla, Texas  75154
(City, state and zip code)

 
 
 

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

[X]
(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
[X]
(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F,11-K, Form N-SAR, or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof  will be filed on or before the fifth calendar day following the prescribed due date; and
 
(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D,  N-SAR, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.

The Registrant is unable to file its 10-Q for period ended  March 31, 2011 in a timely manner because the Registrant is not able to complete its financial statements without unreasonable effort or expense.

PART IV-- OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification
   
 P. Morgan McCune
  
     (800)
  
         843-8171
(Name)
  
(Area Code)
  
(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes [X ] No [  ]


(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
Yes [  ] No [X]
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.


 
 
2
 
 
 

Triple A Medical, Inc. has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.


Date:  May 16, 2011
By:   
/s/ P. Morgan McCune
   
Name:   P. Morgan McCune
   
Title:     President

 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
3